SLU-PP-332 5mg – METABOLIC & ENDURANCE RESEARCH

Description

SLU-PP-332 5MG – ADVANCED METABOLIC & ENDURANCE RESEARCH COMPOUND

SLU-PP-332 (5MG) is a highly selective PPARδ (Peroxisome Proliferator-Activated Receptor Delta) agonist developed for advanced research into metabolic regulation, endurance optimization, and energy utilization pathways. By activating PPARδ, SLU-PP-332 has been shown in research settings to increase fatty acid oxidation, enhance mitochondrial efficiency, and improve stamina-related biochemical responses.

This compound is valued for its ability to promote metabolic flexibility—shifting energy production from carbohydrate to fat utilization—making it a key asset in studies targeting endurance performance, oxidative metabolism, and cellular energy efficiency.

Each 5MG vial of SLU-PP-332 is securely packaged in a sealed, tamper-proof container to maintain maximum purity, potency, and stability. Sourced from iLAB Pharma’s premier production line, it undergoes rigorous third-party testing to ensure research-grade quality and reliability. Designed exclusively for laboratory applications, dosing and administration should follow established research protocols specific to PPARδ modulation studies.

Key experimental benefits include improved oxidative capacity, enhanced fatty acid metabolism, and optimized energy efficiency under endurance conditions. SLU-PP-332 is considered an essential addition to research programs exploring elite-level performance biology and metabolic health optimization.

Potential adverse reactions in research environments are minimal but should be monitored according to protocol. Product is not intended for medical use.

For research and educational purposes only. The customer assumes full responsibility for proper handling and application of this product.